Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Reply of the Editor in Chief

Giuseppe Citerio^{1

2}

Affiliations

¹ Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy. giuseppe.citerio@unimib.it.
² Neurointensive Care Unit, Department of Neuroscience, ASST-Monza, San Gerardo Hospital, Monza, Italy. giuseppe.citerio@unimib.it.

Comment

Giuseppe Citerio. Intensive Care Med. 2022 Jul.

. 2022 Jul;48(7):965-966.

doi: 10.1007/s00134-022-06758-2. Epub 2022 Jun 6.

Giuseppe Citerio^{1

2}

¹ Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy. giuseppe.citerio@unimib.it.
² Neurointensive Care Unit, Department of Neuroscience, ASST-Monza, San Gerardo Hospital, Monza, Italy. giuseppe.citerio@unimib.it.

No abstract available

Comment on

Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.
Bouglé A, Tuffet S, Federici L, Leone M, Monsel A, Dessalle T, Amour J, Dahyot-Fizelier C, Barbier F, Luyt CE, Langeron O, Cholley B, Pottecher J, Hissem T, Lefrant JY, Veber B, Legrand M, Demoule A, Kalfon P, Constantin JM, Rousseau A, Simon T, Foucrier A; iDIAPASON Trial Investigators. Bouglé A, et al. Intensive Care Med. 2022 Jul;48(7):841-849. doi: 10.1007/s00134-022-06690-5. Epub 2022 May 13. Intensive Care Med. 2022. PMID: 35552788 Clinical Trial.
Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia.
Siegrist EA, Sassine J. Siegrist EA, et al. Intensive Care Med. 2022 Jul;48(7):963-964. doi: 10.1007/s00134-022-06754-6. Epub 2022 May 26. Intensive Care Med. 2022. PMID: 35616656 No abstract available.

1. Bouglé A, Tuffet S, Federici L et al (2022) Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial. Intensive Care Med. https://doi.org/10.1007/s00134-022-06690-5 - DOI - PubMed
1. Siegrist EA, Sassine J (2022) Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Intensive Care Med. https://doi.org/10.1007/s00134-022-06754-6 - DOI - PubMed
1. Bouglé A, Tuffet S, Federici L et al (2022) Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial. Intensive Care Med. https://doi.org/10.1007/s00134-022-06776-0 - DOI - PubMed
1. Poole D, De Jong A, Citerio G (2022) Multistakeholder social media peer-review and fixing slips. Intensive Care Med. https://doi.org/10.1007/s00134-022-06747-5 - DOI - PubMed - PMC
1. Csiszar A (2016) Peer review: troubled from the start. Nature 532:306–308. https://doi.org/10.1038/532306a - DOI - PubMed